Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Trimethoprim hydrochloride (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
|
Trimethoprim-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |
Product containing phenazopyridine and sulfamethoxazole and trimethoprim in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
3 |
Phenazopyridine- and sulfamethoxazole- and trimethoprim-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
3 |
Phenazopyridine and sulfamethoxazole and trimethoprim only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
3 |
Product containing only trimethoprim (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |
Product containing only polymyxin B and trimethoprim (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
2 |
Product containing only sulfamethoxazole and trimethoprim (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
2 |
Product containing only phenazopyridine and sulfamethoxazole and trimethoprim in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
3 |
Product containing only trimethoprim in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |
Trimethoprim only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |
Product containing only trimethoprim in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |
Sulfamethoxazole and trimethoprim only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
2 |
Sulfamethoxazole and trimethoprim only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
2 |
Trimethoprim 20 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |
Trimethoprim 20 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |
Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL solution for infusion |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
2 |
Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL solution for infusion |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
2 |
Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
2 |
Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
2 |
Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL oral suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
2 |
Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL oral suspension |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
2 |
Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
3 |
Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
3 |
Product containing isoniazid and pyridoxine and sulfamethoxazole and trimethoprim (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
2 |
Product containing only isoniazid and pyridoxine and sulfamethoxazole and trimethoprim (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
2 |
Isoniazid- and pyridoxine- and sulfamethoxazole- and trimethoprim-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
2 |
Isoniazid and pyridoxine and sulfamethoxazole and trimethoprim only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely isoniazid 300 milligram and pyridoxine hydrochloride 25 milligram and sulfamethoxazole 800 milligram and trimethoprim 160 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
3 |
Product containing precisely isoniazid 300 milligram and pyridoxine hydrochloride 25 milligram and sulfamethoxazole 800 milligram and trimethoprim 160 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
3 |
Product containing precisely sulfamethoxazole 80 milligram/1 milliliter and trimethoprim 16 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely sulfamethoxazole 80 milligram/1 milliliter and trimethoprim 16 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely trimethoprim 300 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely trimethoprim 300 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely trimethoprim 160 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely trimethoprim 160 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Trimethoprim (substance) |
Inferred relationship |
Some |
1 |